Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists
- PMID: 25644592
- PMCID: PMC4373998
- DOI: 10.1016/j.addbeh.2015.01.004
Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists
Abstract
Background: Although smoking-cessation interventions typically focus directly on patients, this paper conducts an economic evaluation of a novel smoking-cessation intervention focused on training physicians and/or pharmacists to use counseling techniques that would decrease smoking rates at a reasonable cost.
Purpose: To evaluate the cost-effectiveness of interventions that train physicians and/or pharmacists to counsel their patients on smoking-cessation techniques.
Methods: Using decision-analytic modeling, we compared four strategies for smoking-cessation counseling education: training only physicians, training only pharmacists, training both physicians and pharmacists (synergy strategy), and training neither physicians nor pharmacists (i.e., no specialized training, which is the usual practice). Short-term outcomes were based on results from a clinical trial conducted in 16 communities across the Houston area; long-term outcomes were calculated from epidemiological data. Short-term outcomes were measured using the cost per quit, and long-term outcomes were measured using the cost per quality-adjusted life-year (QALY). Cost data were taken from institutional sources; both costs and QALYs were discounted at 3%.
Results: Training both physicians and pharmacists added 0.09 QALY for 45-year-old men. However, for 45-year-old women, the discounted quality-adjusted life expectancy only increased by 0.01 QALY when comparing the synergy strategy to no intervention. The incremental cost-effectiveness ratio (ICER) of the synergy strategy with respect to the non-intervention strategy was US$868/QALY for 45-year-old men and US$8953/QALY for 45-year-old women. The results were highly sensitive to the quit rates and community size.
Conclusion: Synergistic educational training for physicians and pharmacists could be a cost-effective method for smoking cessation in the community.
Keywords: Costs and cost analysis; Medical decision making; Nicotine; Smoking cessation.
Published by Elsevier Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Abelin T, Buehler A, Muller P, Vesanen K, Imhof PR. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet. 1989;1:7–10. - PubMed
-
- Bolin K, Lindgren B, Willers S. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden. Chest. 2006;129:651–660. - PubMed
-
- Cantor SB. Decision analysis: theory and application to medicine. Primary Care: Clinics in Office Practice. 1995;22:261–270. - PubMed
-
- Cantor SB, Miller L. Time horizon. In: Kattan M, editor. Encyclopedia of medical decision making. Thousand Oaks, CA: SAGE Publications, Inc.; 2009. pp. 1138–1139.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
